positron-emission-tomography

Documents about positron-emission-tomography

• Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors#873956ClinicalTrials.gov
• eMESH Struct. 2022-23#894624ClinicalTrials.gov
• C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer#905917ClinicalTrials.gov
• Association of Processing Speed Dysfunction and Brain Functional Abnormality in ECTS#916392ClinicalTrials.gov
• Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases#967410ClinicalTrials.gov
• Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)#991740ClinicalTrials.gov
• Utility of dynamic (18)F-fluoroethyl-L-tyrosine positron emission tomography in determining pseudoprogression from tumor recurrence in the 6 months following radiation therapy for glioblastoma.#135807NCBI PubMed Central
• FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer#312103HAL (France)
• Impact of Grape Consumption on Brain Metabolism and Cognitive Function#844438ClinicalTrials.gov
• Association of Preoperative Hippocampal Glucose Metabolism With Postoperative Delirium in Older Diabetic Patients#859471ClinicalTrials.gov
• Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)#861688ClinicalTrials.gov
• A Study Using 18F-FAZA and PET Scans to Study Hypoxia in Pancreatic Cancer#875598ClinicalTrials.gov
• High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer#875612ClinicalTrials.gov
• Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects#895218ClinicalTrials.gov
• Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy#1007009ClinicalTrials.gov
• Développement d'un module de détection phoswich LSO/LuYAP pour le prototype de caméra à positrons ClearPET#401940DataCite
• Baseline FDG-PET Brain hypometabolism as a predictive biomarker of cognitive decline and Alzheimer's disease risk#182055Europe PMC
• Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts#826548ClinicalTrials.gov
• Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer#839027ClinicalTrials.gov
• Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors#850206ClinicalTrials.gov
• A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)#855752ClinicalTrials.gov
• Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172#873138ClinicalTrials.gov
• Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing#886521ClinicalTrials.gov
• FDG-PET/CT Images Comparing to MRI and Endomyocardial Biopsy in Myocarditis#892834ClinicalTrials.gov
• Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome#896708ClinicalTrials.gov
• Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes#906084ClinicalTrials.gov
• [68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer Patients#968507ClinicalTrials.gov
• Étude de la propagation optique et de son impact sur les performances intrinsèques de modules de détection TEP non conventionnels#129396HAL (France)
• Positron Emission Tomography(PET) in Lymphoma Assessment#800442ClinicalTrials.gov
• A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer#807160ClinicalTrials.gov
• PET Imaging of PARP Activity in Cancer#841549ClinicalTrials.gov
• The Neural Mechanisms of Anesthesia and Human Consciousness#847259ClinicalTrials.gov
• Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer#856862ClinicalTrials.gov
• A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers#887182ClinicalTrials.gov
• Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy#898559ClinicalTrials.gov
• 18 F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study#670155HAL (France)
• Mathematical Modeling of Brain Energy Metabolism, Measured with PET and MRS in Rodents#367513Infoscience
• Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood Pharmacokinetics#370726HAL (France)
• Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein#801449ClinicalTrials.gov
• PSMA-PET Imaging Before and After ADT in Advanced SDC Patients#851109ClinicalTrials.gov
• PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment#871250ClinicalTrials.gov
• Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving Chemotherapy#872421ClinicalTrials.gov
• Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)#879368ClinicalTrials.gov
• PET Imaging of Brain Amyloid Using [11C]MeS-IMPY#908589ClinicalTrials.gov
• A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan#808122ClinicalTrials.gov
• Whole brain grey matter synaptic terminal density, age and intellectual functioning in schizophrenia: an in vivo [<sup>11</sup>C]UCB-J positron emission tomography study#205495Europe PMC
• Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis#882395ClinicalTrials.gov
• Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)#909412ClinicalTrials.gov
• [18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica#969023ClinicalTrials.gov
• Assessment of Positron Emission Tomography to Early Detect Frailty in Onco-geriatry#982059ClinicalTrials.gov